Dalton, Greiner, Hartman, Maher & Co’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
Dalton, Greiner, Hartman, Maher & Co's ABT Position: Q3 2020 in Review
Dalton, Greiner, Hartman, Maher & Co sold out of Abbott (ABT) in Q3 2020, closing a stake of 24,378 shares — an estimated $2.23M sold.
Dalton, Greiner, Hartman, Maher & Co first reported a position in ABT in Q1 2014 and held it in 26 quarters. The position peaked at $31.5M in Q2 2014. 2,306 funds tracked by Wall St. Rank hold ABT as of Q3 2020.
- Dalton, Greiner, Hartman, Maher & Co reported no remaining Abbott position as of Q3 2020 after selling out during the quarter.
- Dalton, Greiner, Hartman, Maher & Co sold 24,378 Abbott shares in Q3 2020, an estimated $2.23M.
- Dalton, Greiner, Hartman, Maher & Co first reported a position in Abbott in Q1 2014 and held it in 26 quarters.
- Dalton, Greiner, Hartman, Maher & Co's Abbott position peaked at $31.5M in Q2 2014.
- 2,306 funds tracked by Wall St. Rank held Abbott as of Q3 2020.
Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q3 2020, filed 9 Oct 2020.